Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies

Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies

US Patent 5628996 · Granted May 13, 1997

Estimated economic value: $142,354,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of IL-31 monoclonal antibodies for treating pruritus2019
Use of IL-31 monoclonal antibodies for reducing pruritus2019
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies2019
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies2018
Method of reducing pruritus using IL-31 monoclonal antibodies2017
Method of treating atopic dermatitis with IL-31 monoclonal antibodies2017
Polynucleotides encoding IL-31 monoclonal antibodies2017
IL-31 monoclonal antibodies2016
Polynucleotides encoding IL-31 monoclonal antibodies2015
Variable region sequences of IL-31 monoclonal antibodies and methods of use2015
Anti-IL-20 antibodies and binding partners and methods of using in inflammation2014
Method of reducing pruritis using IL-31 monoclonal antibodies2013